Summary.-Lymphocytes infiltrating human primary mammary carcinomas lack ADCC and show low levels of natural cytotoxicity. The peripheral blood lymphocytes, however, show a variable but prominent level of cytotoxicity. Lymphocyte preparations from breast tumours, when mixed with autologous blood lymphocytes, significantly suppress their prominent killer-(K-and NK-) cell activities.
VARIOUS ANTI-TUMOUR host-defence mechanisms have been postulated to operate in man, and in particular the possible beneficial role of lymphocytic killer cells has been invoked (Cerottini & Brunner, 1974; Henney, 1977; . A possible explanation for the improved survival and reduced potential to metastasize, seen with extensive lymphocytic infiltrates of primary tumours (for review see Underwood, 1974) , is the in situ tumour cell damage mediated by the infiltrating killer lymphocytes.
The presence of a prominent lymphocytic infiltrate within mammary carcinomas has been found by many investigators to be a favourable prognostic sign (Moore & Foote, 1948; Berg, 1959; Anastassiades & Pryce, 1966; Hamlin, 1 968; Cutler et al., 1969; Di Paola et al., 1974; Fisher et al., 1975 ). The precise anti-tumour role of the tumour-infiltrating lymphocytes, however, is as yet improperly understood.
We have previously described antibodydependent cellular-cytotoxicity (ADCC) mediated by killer (K) cells, and natural cytotoxicity mediated by natural killer (NK) cells, in the peripheral blood and regional tumour-draining lymph nodes of patients with mammary carcinoma, clinically localized to the breast and axilla (Eremin et al., 1977a; 1978a) . In this communication we report our findings on the K and NK activity of lymphocytes isolated from the primary mammary carcinomas removed at operation from such patients.
METHODS

Blood lymphocyte preparation
Venous blood, from healthy adult volunteers and patients with breast cancer, was collected by venepuncture into syringes containing preservative-free heparin (30 i.u./ml). The patients were women, aged 40-67 years, with a clinical Stage I or II mammary carcinoma confined to the breast and axilla. Lymphocytes were isolated from the heaprinized blood on a Ficoll-Hypaque gradient, washed and made up in tissue-culture medium (TCM). TCM consisted of RPMI 1640 with 10% heat-inactivated foetal calf serum, (0 7 gIl) streptomycin (100 jtg/l) and penicillin G (100,000 i.u./l).
To assess the effect of the various methodological procedures on K and NK activity, some of the blood lymphocytes were further treated as follows: (a) 107 lymphocytes were incubated with 15 ml of collagenase (Sigma, Type 1-see below) at 37°C for varying periods of time (1-24 h Enzymatic digestion.-The small, choppedup pieces were then incubated in collagenase (Sigma, Type 1) at 37°C for 11-14 h. (The collagenase, 300 u./ml, was dissolved in TCM (protein-free), filter-sterilized and stored at -30°C.) The prolonged incubation of the tumour pieces produced a thick cell suspension, which was washed x 6 with TCM and passed through sterile gauze layers to remove residual stromal fragments and debris. This procedure usually yielded a substantial number of viable cells (5-50 x 106) depending primarily on the size of the tumour specimen processed. The lymphocytes, consisting of a variable percentage of the total cell yield, were isolated from such enzyme preparations by passage on Sephadex G-10 columns (see below). Lymphocyte numbers, viability and contamination by macrophages was reassessed in the column eluate. Occasionally there was a heavy contamination by red blood cells, which were removed by lysis with deionized water-a procedure known not to reduce killer-cell activity (Eremin et al., 1978b) .
Cell size and viability were assessed by phase-contrast microscopy. Surface-marker characteristics were determined by various resetting assays and the data presented in Eremin et al. (submitted) . Where possible, 12 morphology was characterized further by stained smears or cytocentrifuge preparations.
Sephadex G-10 columns Sephadex G-10 columns, as described previously (Eremin et al., 1980b; Kanski et al., 1981) were used to isolate lymphocytes from enzymatically digested tumour-cell preparations, the much larger macrophages and tumour cells being trapped on the column. This procedure has been found not to deplete selectively different lymphocyte subsets, irrespective of the source of the lymphocytes.
Cytotoxicity assays
ADCC was determined by an in vitro 3h, 51Cr-release assay as previously described (Eremin et al., 1977a) . The target cells used were CLA4, a lymphoblastoid cell line growing as a suspension culture (Epstein-Barr-virus positive) and Detroit 6 (D6), growing as a monolayer (Eremin et al., 1977a) . The target cells were coated with human anti-HLA serum (1: 500) or with rat IgG anti-D6 antibody (1:400). Effector cells were blood lymphocytes (normal, collagenase-treated and Sephadex G-10 passaged), total-cell preparations from breast tumours (mechanical disaggregation and collagenase digestion), lymphocytes isolated from breast-tumour preparations (collagenase digestion and Sephadex G-10 passage, mechanical disaggregation) and lymphocytes isolated from breast-tumour preparations (collagenase digestion and Sephadex G-10 passage) and depleted of T lymphocytes. The effector:target-cell ratio was 40:1, 20:1 and 0:1. Natural cytotoxicity was determined by an in vitro, 24h, 51Cr-release assay as described by Eremin et al. (1978a) . The target cells were CLA4 and D6, and the effector cells were as outlined above.
Percentage isotope released was calculated, and assays were statistically evaluated by analysis of variance on the logarithm of the percentage isotope released. Duncan's multiple-range testing was used to assess the significance of the various treatments on ADCC and NK cytotoxicity.
Lymphocyte surface markers
Lymphocyte surface markers were determined by various rosetting assays. The thymus-derived E-rosetting lymphocytes were enumerated as described by Eremin et al. 1l67 0. EREMIN, R. R. A. COOMBS AND J. ASHBY (1976) . Briefly, sheep red blood cells (1% suspension) were rosetted with lymphocytes (2 x 106/ml) in the presence of 30% foetal calf serum (absorbed with SRBC), by centrifuging at 200 g for 3 min and allowing to stand for 1 h at room temperature. The slg-bearing B lymphocytes were detected by the direct antiglobulin rosetting (DAR) assay, using chromic chloride to couple the rabbit anti-human Fab to trypsin-treated ox red blood cells (Coombs et al., 1977) .
Surface-marker profiles were done on the following preparations of tumour-infiltrating lymphocytes: (1) The latter could not be detected even with the very sensitive DAR assay (Coomb et al., 1977) . The tumour-infiltrating lymphocytes (10-50% of the total mononuclear cell population, and in absolute terms 5x 105-22 x 106) were composed of both T and B lymphocytes and their various subsets (Eremin et al., submitted) . In most cases the tumour-infiltrating lymphocytes were isolated from the tumour-cell preparations by passage through Sephadex G-10 columns. On average, 440/o (30-57%) of the tumour-infiltrating lymphocytes were recovered from the column, and on average 85% (76-94%) of the mononuclear cells eluted from the column were lymphocytes, the contaminants being > 70%/ macrophages.
Most of the breast tumours were scirrous and relatively avascular and the very low erythrocyte: lymphocyte ratio suggested minimal contamination by blood elements.
Tumour -infiltrating lymphocyte preparations lack K-cell activity Figs 1, 2 & 5 show the total absence of ADCC in lymphocyte preparations obtained from primary mammary carcinomas, which was seen whether target cells were coated with human or rat IgG antibodies. This total lack of K-cell activity was seen in 14/16 breast-tumour specimens (Fig. 5 ). In the remaining 2 specimens there was a very low K-cell activity, the breast-tumour preparation (before column passage) being associated with a relatively heavy contamination by RBC and presumably by K cells, from the intravascular compartment of the tumour. failed to restore the K-cell activity (data not shown); pre-incubating the lymphocytes at 37TC for 24 h also failed to restore the absent ADCC (see Fig. 8 ). Longer incubations (48-72 h) also failed to restore the ADCC (data not shown).
Peripheral-blood lymphocyte preparations, on the other hand, from all the patients tested showed a variable but prominent K-cell activity (Figs 1, 2 & 5).
Tumour -infiltrating lymphocyte preparations show a low and significantly reduced NK activity
The natural cytotoxicity of lymphocytes isolated from primary breast tumours was either low or totally lacking (Figs 3, 4 & 5) . This pattern of NK activity was seen (a) whether the method used to prepare ,,--z :8:-:. The peripheral-blood lymphocytes, on the other hand, from all 15 patients showed a variable but very prominent NK activity (Fig. 5) .
Incubation of blood lymphocytes with collagenase did not reduce K and NK activity As can be seen from Fig. 6 To exclude the possibility that the absence of K and the low NK activity of the breast-tumour-infiltrating lymphocytes was due to the selective retention of K and NK cells on the Sephadex G-10 column, the ADCC and NK cytotoxicity of blood lymphocytes before and after column passage were determined. The results (Fig. 7) show convincingly that the Sephadex G-10 column did not selectively remove K and NK cells from the blood-lymphocyte suspensions. Sephadex G-10 columns had been shown in a previous study not to deplete different lymphocyte subsets (Kanski et al., 1981) . G-10-column-passage produced no significant difference in ADCC and natural cytotoxicity.
Suppression of blood K and NK activities by lymphocyte preparations from breast tumours Figs 8, 9 & 10 reveal convincingly that ADCC and NK cytotoxicity of blood lymphocytes could be substantially reduced by the addition of tumour-infiltrating lymphocyte preparations. Previous studies (Eremin et al., 1977b; 1978c) Statistically significant reduction of ADCC in (A) and (B) when tumour-infiltrating lymphocyte preparations were added to patients' blood-lymphoctye suspensions (P < 0.001).
incubation of the lymphocyte preparations at 37TC on a glass surface in the presence of 10% foetal calf serum (Figs 8, 9 & 10) . Pretreatment of tumour-infiltrating lymphocytes with carbonyl iron was also unsuccessful (data not shown). The lack of glass adherence and phagocytosis suggested a non-macrophage-like cell. We iave preliminary data, however, showing reduced phagocytic capacity and poor glass-adherence properties of the macrophages within mammary cancers. Thus, since all the lymphocyte preparations had a small population of contaminating tumour macrophages, it was not possible to determine unequivocally the precise nature of this "suppressor" cell.
Removal of E-rosetting T lymphocytes fails to alter the low level of NK-cell activity
The low level of NK activity in some preparations of tumour-infiltrating lym- phocytes was unaltered by depletion of the E-rosetting thymus-derived lymphocytes (Fig. 11) . The T depleted population was also able to suppress the prominent NK activity of the patients' blood lymphocytes. The low levels of cytotoxicity, therefore, are unlikely to be due to migration of E-rosetting thymus-derived NK cells from the regional draining lymph nodes (Eremin et al., 1 978c).
I)ISCUSSION
The present study has revealed that lymphocytes infiltrating primary mammary carcinomas, in women clinically assessed as potentially curable, lack K-cell activity and show low or absent levels of NK-cell (Vose et al., 1977; Totterman et al., 1978; Gerson et al., 1979; Vose & Moore, 1979) . The present investigation thus corroborates and documents more fully the low levels of natural cytotoxicity detected in lymphocyte preparations from human mammary carcinomas.
In contrast to the findings in man, tumour-infiltrating lymphocytes isolated from Moloney sarcoma virus-induced tumours in mice (Becker & Klein, 1976; Gerson et al., 1979) and methyleholanthrene-induced sarcomas in rats show high levels of natural cytotoxicity, comparable to that in spleen. Should this prove to be a consistent finding, it would represent an important and possibly crucial difference between some animal tumour models and the common solid tumours of man.
Very few investigations of ADCC in lymphocyte suspensions isolated from human solid tumours have been published. ADCC has been described in host infiltrating cells isolated from some animal tumours. Haskill & Parthenais (1978) described, using an in vitro colony inhibition and micro-cytotoxicity assay, monocyte effector cells mediating ADCC, but they failed to find evidence for the lymphocytic killer (K) cell.
Investigations have precluded the possibility that the methodology used to isolate the tumour-infiltrating lymphocytes (collagenase digestion, Sephadex G-10 columns) was responsible for the low level of killer-cell (K and NK) activity detected. Also, low levels of killer-cell activity were seen, whatever technique was used to isolate the tumour-infiltrating lymphocytes.
Prolonged washing or incubation at 37°C failed to augment the lytic capacity of the tumour-infiltrating lymphocytes, suggesting that receptor blockade was probably not responsible for the low levels of cytotoxicity detected. Data from previous investigations (Eremin et al., 1977b (Eremin et al., , 1978c had shown that blockage of the Fc(IgG) receptor abolished K-cell activity but had no effect on NK-cell activity.
The present investigation also revealed that the tumour lymphocyte preparations were able to reduce substantially the prominent K and NK activity of the patients' autologous blood lymphocytes.
Lymphocytes modulating or "suppressing" such lytic mechanisms have been recently described in man (Parkman & Rosen, 1976; Eremin et al., 1977b; Pollack & Herrick, 1977; Osband & Parkman, 1978) . Removal of adherent or phagocytic cells had no effect on the inhibitory capacity of the cell preparations, further suggesting a lymphocytic suppressor cell. These procedures, however, never completely removed all the contaminating macrophages, and the lymphocytic nature of the suppressor cell was not established unequivocally.
Since the different lymphocyte preparations from the mammary carcinomas were contaminated (to a variable degree) by macrophages and/or breast-tumour cells, the absent or minimal cytotoxicity detected in these preparations could possibly be due to a competitive inhibitory effect by the "cold" contaminating cells (Ortaldo et al., 1977; Vose & Moore, 1980) . This possibility was unlikely, however, for the reasons outlined below.
Firstly, in relation to ADCC, the breasttumour cells (assessed morphologically) in our different preparations lacked surface immunoglobulin, whilst the macrophageacquired immunoglobulin (reacting with the anti-human Fab reagent) was probably cytophilically acquired and attached via the Fe piece. Neither cell would appear therefore to be a suitable competitor cell in ADCC, as they lacked the exposed Fc portion of IgG. This fact was established by our earlier unpublished findings, showing that the addition of tumour-cell preparations (not passaged through Sephadex G-10 and with a very low lymphocyte content) to standard ADCC assays at contaminant or "blocker": target-cell ratios of 1 :1 to 4:1 had no effect on K-cell activity. The average contamination by tumour cells and/or macrophages in our tumour-lymphocyte preparations was 15%, the contaminant: target-cell ratio therefore being 3:1 at effector:target-cell ratios of 20:1, which in most blood lymphocyte preparations was on the plateau of maximal lytic activity (see Fig. iB, C) . In some specimens the contamination by non-lymphocytic mononuclear cells was much lower (e.g. 7%), the "blocker" target-cell ratios now being 3:1 at effector: target-cell ratios of 40:1 (Fig. IA) . In all the above experiments, as well as in virtually all the rest, ADCC was absent.
Secondly in relation to NK-cell activity, as can be seen from Figs 3 and 4, where the contamination by "cold" tumour cells in all experiments was < 50 % and the "blocker" : target-cell ratio < 2:1 at effector target-cell ratio of 40:1, the NK activity was low or absent. In Figs 9B and 1OB, following preincubation of the tumour-infiltrating lymphocytes for 24 h, contamination by breast-tumour cells was very low (<1 %) but inhibition of autologous NK activity was still seen. Previous studies had shown that the addition of "cold" tumour cells to standard in vitro NK-cell assays, using blood lymphocytes as effector cells, even at "blocker": targetcell ratios of 4:1, failed to inhibit cytotoxicity (unpublished data). These findings suggest that the low or absent NK activity of tumour-infiltrating lymphocytes was not due to competitive inhibition by contaminating "cold" tumour cells.
We have previously characterized the human K and NK cells in blood, and found them to be IgG Fc-receptor-bearing B lymphocytes, but lacking a receptor for the third component of complement (Fc+ C3-) (Eremin et al., 1977b; 1978c) . The (Fc+ C3+) lymphocyte subpopulation not only lacked lytic capacity, but could modulate K and NK activities (Eremin et al., 1977b (Eremin et al., , 1978c . A detailed study of the lymphocyte subpopulations within breast tumours (Eremin et al., submitted) has revealed the presence of IgG Fcreceptor-bearing lymphocytes. Mixed rosetting reactions revealed, however, a low level (both in terms of percentage and absolute numbers) of (Fc+ C3-) lymphocytes; i.e., according to our previously reported findings, a paucity of K and NK cells and the presence of "suppressor" lymphocytes.
Our previous studies have also revealed that although lymph nodes lack K cells they have thymus-derived NK cells, in contrast to the findings in blood (Eremin et al., 1977b (Eremin et al., , 1978c . The present investigation, however, failed to confirm the presence of such NK cells within the tumourcell milieu, and corroborates the evidence presented in Eremin et al. (submitted) suggesting an intravascular origin for the infiltrating lymphocytes.
The lymphocytes within breast tumours therefore presumably originate from the intravascular compartment permeating the growth. Whether the migration of lymphocytes and particularly K and NK cells into the tumour substance through the vascular endothelium is selective and initiated by immunological factors is uncertain (Emeson, 1978; Haskill & Parthenais, 1978; Radov et al., 1979) . Selective damage of lymphocyte subpopulations within the tumour, retention and/or selective proliferation may all be operative to varying degrees in the complex tumourhost infiltrative-cell milieu. If ADCC and NK cytotoxicity do indeed have a hostdefensive role to play (as yet unproven), the cellular milieu of the tumour is such as to favour continued tumour growth.
